Lexatumumab

From WikiMD.org
Jump to navigation Jump to search
Lexatumumab
TermLexatumumab
Short definitionLexatumumab (lek-suh-TOO-moo-mab) A substance being studied to treat some types of cancer. It attaches to a protein called TRAIL-R2 on the surface of some tumor cells, which can kill the tumor cells. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Lexatumumab - (pronounced) (lek-suh-TOO-moo-mab) A substance being studied to treat some types of cancer. It attaches to a protein called TRAIL-R2 on the surface of some tumor cells, which can kill the tumor cells. Lexatumumab is a type of monoclonal antibody. Also called Anti-TRAIL R2 mAb HGS-ETR2 and HGS-ETR2

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski